Litcius/Paper detail

The effect of Mexidol on cerebral mitochondriogenesis at a young age and during aging

Yu. I. Kirova, F. M. Shakova, E. L. Germanova, G. A. Romanova, Т. А. Воронина

2020S S Korsakov Journal of Neurology and Psychiatry26 citationsDOI

Abstract

AIM: To study the ability of mexidol to induce cerebral mitochondriogenesis in the brain of young and aging rats. MATERIAL AND METHODS: Expression level of marker proteins of cerebral mitochondriogenesis was evaluated during treatment with mexidol (20, 40, 100 mg/kg; 20 days; intraperitoneally) in the cerebral cortex of young (3 month) and aging (6, 9, 12, and 15 month) outbred male rats, using the Western blot analysis. RESULTS: It has been shown for the first time that the course injections of mexidol in doses of 40 and 100 mg/kg is accompanied by dose-dependent induction of the succinate receptor SUCNR1 and protein markers of mitochondrial biogenesis: transcription coactivator PGC-1α, transcription factors (NRF1, TFAM), catalytic subunits of respiratory enzymes (NDUV2, NDUV2,cytb, COX2) and ATP synthase (ATP5A) in the cerebral cortex of young and aging outbred male rats. Mexidol-dependent overexpression of subunits of mitochondrial enzymes and PGC-1α is observed only with the course of the drug. CONCLUSION: The results indicate the ability of mexidol to induce cerebral mitochondriogenesis and eliminate mitochondrial dysfunction in young and aging animals and, thus, exert an effect on one of the key pathogenetic links of the development of disorders in aging and neurodegenerative diseases.

Topics & Concepts

TFAMNRF1Mitochondrial biogenesisMedicineCerebral cortexWestern blotCitrate synthaseSDHAMitochondrionEndocrinologyBrain agingInternal medicineEnzymeCell biologyGeneSuccinate dehydrogenaseBiochemistryBiologyDiseaseNeurological Disorders and TreatmentsNeurological Disease Mechanisms and TreatmentsBiochemical Acid Research Studies